These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26514119)

  • 21. Surveillance, epidemiology, and end results-based analysis of the impact of preoperative or postoperative radiotherapy on survival outcomes for T3N0 rectal cancer.
    Peng LC; Milsom J; Garrett K; Nandakumar G; Coplowitz S; Parashar B; Nori D; Clifford Chao KS; Wernicke AG
    Cancer Epidemiol; 2014 Feb; 38(1):73-8. PubMed ID: 24491755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of preoperative radiotherapy on survival in locally advanced rectal cancer: an observational population-based study from the South of Switzerland.
    Spitale A; Franzetti-Pellanda A; Mazzola P; Richetti A; Mazzuchelli L; Bordoni A
    Eur J Cancer Prev; 2012 Mar; 21(2):139-46. PubMed ID: 22252302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
    Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
    Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection.
    Moore HG; Gittleman AE; Minsky BD; Wong D; Paty PB; Weiser M; Temple L; Saltz L; Shia J; Guillem JG
    Dis Colon Rectum; 2004 Mar; 47(3):279-86. PubMed ID: 14991488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of obesity in rectal cancer surgery.
    Chern H; Chou J; Donkor C; Shia J; Guillem JG; Nash GM; Paty PB; Temple LK; Wong WD; Weiser MR
    J Am Coll Surg; 2010 Jul; 211(1):55-60. PubMed ID: 20610249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant radiation therapy for rectal carcinoma: predictors of outcome.
    Myerson RJ; Michalski JM; King ML; Birnbaum E; Fleshman J; Fry R; Kodner I; Lacey D; Lockett MA
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):41-50. PubMed ID: 7721638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of preoperative concurrent chemoradiotherapy in locally advanced low rectal cancer after radical resection surgery.
    Lam CW; Chen WT; Liu MT; Chang CS; Huang TM; Hsu GH; Chen HC; Hsiao KH; Chiu CM; You JJ
    Int Surg; 2005; 90(1):53-9. PubMed ID: 15912902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation.
    Guillem JG; Chessin DB; Shia J; Suriawinata A; Riedel E; Moore HG; Minsky BD; Wong WD
    Ann Surg; 2007 Jan; 245(1):88-93. PubMed ID: 17197970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
    Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography.
    Stipa F; Chessin DB; Shia J; Paty PB; Weiser M; Temple LK; Minsky BD; Wong WD; Guillem JG
    Ann Surg Oncol; 2006 Aug; 13(8):1047-53. PubMed ID: 16865595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy.
    Marsh RD; Chu NM; Vauthey JN; Mendenhall WM; Lauwers GY; Bewsher C; Copeland EM
    Cancer; 1996 Jul; 78(2):217-25. PubMed ID: 8673995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The outcome and the frequency of pathological complete response after neoadjuvant radiotherapy in curative resections for advanced rectal cancer: a population-based study.
    Wasmuth HH; Rekstad LC; Tranø G
    Colorectal Dis; 2016 Jan; 18(1):67-72. PubMed ID: 26201935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative Survival of Patients With Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma.
    Franklin RA; Giri S; Valasareddy P; Lands LT; Martin MG
    Clin Colorectal Cancer; 2016 Mar; 15(1):47-53. PubMed ID: 26362848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
    Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
    Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center.
    Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK
    Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoadjuvant Radiotherapy: A Risk Factor for Short-Term Wound Complications after Radical Resection for Rectal Cancer?
    Holubar SD; Brickman RK; Greaves SW; Ivatury SJ
    J Am Coll Surg; 2016 Aug; 223(2):291-8. PubMed ID: 27112126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival outcome of adjuvant radiotherapy after local excision for T2 early rectal cancer: An analysis based on the surveillance, epidemiology, and end result registry database.
    Wang XJ; Chi P; Zhang YY; Lin HM; Lu XR; Huang Y; Xu ZB; Ghareeb WM; Huang SH; Sun YW; Ye DX
    Eur J Surg Oncol; 2018 Dec; 44(12):1865-1872. PubMed ID: 30262325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
    J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor response and negative distal resection margins of rectal cancer after hyperthermochemoradiation therapy.
    Tsutsumi S; Tabe Y; Fujii T; Yamaguchi S; Suto T; Yajima R; Morita H; Kato T; Shioya M; Saito J; Asao T; Nakano T; Kuwano H
    Anticancer Res; 2011 Nov; 31(11):3963-7. PubMed ID: 22110227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.